Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tyrosine kinase inhibitor
Biotech
Alumis raises $259M in 2024's largest biotech round so far
Alumis has reeled in an eye-watering $259 million series C, financing that will help launch a phase 3 psoriasis trial for lead asset ESK-001.
Gabrielle Masson
Mar 6, 2024 8:00am
Yuhan makes $325M cancer bet to challenge Boehringer, Takeda
May 31, 2023 9:45am
Gilead culls 3 programs, including 2 of 3 KRAS4 indications
Feb 3, 2023 5:45am
FDA rejection prompts Spectrum to cut 75% of R&D workforce
Nov 28, 2022 7:50am
IDRx nabs $122M to address precision medicine 'whack-a-mole'
Aug 2, 2022 6:30am
AbbVie pens Imbruvica pact to support pivotal Oncternal trial
Jul 15, 2022 9:55am
